cyclosporine has been researched along with Immunoblastic Large-Cell Lymphoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Goh, YT; Gopalakrishnan, S; Grigoropoulos, NF; Ho, LP; Hwang, WYK; Lee, YS; Nagarajan, C; Phipps, C; Yeoh, KW | 1 |
| Bellin, MF; Dion, E; Drahy, G; Faucher, C | 1 |
2 other study(ies) available for cyclosporine and Immunoblastic Large-Cell Lymphoma
| Article | Year |
|---|---|
Durable remission is achievable with localized treatment and reduction of immunosuppression in limited stage EBV-related plasmablastic lymphoma.
Topics: Aged; Brentuximab Vedotin; Combined Modality Therapy; Cyclosporine; Dose-Response Relationship, Drug; Epstein-Barr Virus Infections; Herpesvirus 4, Human; Humans; Immunoconjugates; Immunosuppression Therapy; Kidney Transplantation; Lymphoma, Large-Cell, Immunoblastic; Male; Neoplasm Staging; Plasmablastic Lymphoma; Radiotherapy; Remission Induction | 2017 |
[Renal lymphoma in a patient after kidney transplantation and cyclosporine therapy].
Topics: Cyclosporine; Humans; Immunosuppressive Agents; Kidney Transplantation; Lymphoma, Large-Cell, Immunoblastic; Male; Middle Aged; Time Factors | 1992 |